Smart device maker Aradigm aims to seek more market funds if bid for development partnership fails
This article was originally published in Clinica
Executive Summary
Aradigm, a US developer of hand-held smart devices for pulmonary delivery of therapeutics and imaging agents, may return to the market early next year for a further tranche of investor funds, according to its president and CEO, Richard Thompson.